Latest Articles
Walmart+ members can snag the Dyson V12 Detect Slim for $399.99 - Mashable
Walmart+ members can snag the Dyson V12 Detect Slim for $399.99 Mashable
Published: April 13, 2026, 10 p.m.
Lena Dunham's Chronic Illness Battle - The Pain She Hid While the World Was Busy Hating Her - privatetherapyclinics.co.uk
Lena Dunham's Chronic Illness Battle - The Pain She Hid While the World Was Busy Hating Her privatetherapyclinics.co.uk
Published: April 13, 2026, 9:40 p.m.
Eiza González Says It Took ‘Decades’ to Get Diagnosed with PCOS, Endometriosis and Adenomyosis: ‘Years of Gaslighting’ - AOL.com
Eiza González Says It Took ‘Decades’ to Get Diagnosed with PCOS, Endometriosis and Adenomyosis: ‘Years of Gaslighting’ AOL.com
Published: April 13, 2026, 9:30 p.m.
Endometriosis: ‘I was vomiting green. It’s like cancer without being cancer.’ - Luxembourg Times
Endometriosis: ‘I was vomiting green. It’s like cancer without being cancer.’ Luxembourg Times
Published: April 13, 2026, 4 p.m.
Near-Perfect Disease Control for Bispecific in Advanced Endometrial Cancer - MedPage Today
Near-Perfect Disease Control for Bispecific in Advanced Endometrial Cancer MedPage Today
Published: April 13, 2026, 3:43 p.m.
BioNTech Reports Strong Phase 2 Data for HER2-Targeted ADC in Recurrent Endometrial Cancer - TipRanks
BioNTech Reports Strong Phase 2 Data for HER2-Targeted ADC in Recurrent Endometrial Cancer TipRanks
Published: April 13, 2026, 12:29 p.m.
BBC Breakfast's Naga Munchetty left 'curled up on the floor screaming' after 'extreme pain' - Manchester Evening News
BBC Breakfast's Naga Munchetty left 'curled up on the floor screaming' after 'extreme pain' Manchester Evening News
Published: April 13, 2026, 12:22 p.m.
Maine braces for another tick season amid promising Lyme vaccine trials - newscentermaine.com
Maine braces for another tick season amid promising Lyme vaccine trials newscentermaine.com
Published: April 13, 2026, 12:16 p.m.
Biontech prepares FDA application after strong phase II results in endometrial cancer - medwatch.com
Biontech prepares FDA application after strong phase II results in endometrial cancer medwatch.com
Published: April 13, 2026, 12:14 p.m.
Endometrial cancer trial: BioNTech (Nasdaq: BNTX) ADC hits Phase 2 goal - Stock Titan
Endometrial cancer trial: BioNTech (Nasdaq: BNTX) ADC hits Phase 2 goal Stock Titan
Published: April 13, 2026, 11:55 a.m.
Link copied to clipboard!